J

Researcher Profile

J. Spahn

1

Publications

79

Citations

10

Co-Authors

1

Active Years

Publications

Open Access Journal Article Annals of Oncology Sep 01, 2024

LBA39 Updated efficacy and safety data from IMbrave050: Phase III study of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients (pts) with resected or ablated high-risk hepatocellular carcinoma (HCC)

A. Yopp · M. Kudo · M. Chen · A-L. Cheng +9 more

10.1016/j.annonc.2024.08.2279 79 citations

Publication Timeline

2024

1

Frequent Co-Authors